Gynaecological disorders, such as cervical, ovarian, and
endometrial cancers are the second most prevalent
cancer types in women worldwide. Therapeutic approaches for gynaecological
cancers involve
chemotherapy, radiation, and surgery. However, lifespan is not improved, and novel medications are required. Among various
phytochemicals,
berberine, a well-known natural product, has been shown to be a promising
cancer chemopreventive agent. Pharmacokinetics, safety, and efficacy of
berberine have been investigated in the several experiments against numerous diseases. Here, we aimed to provide a literature review from available published investigations showing the anticancer effects of
berberine and its various synthetic analogues against gynaecological disorders, including cervical, ovarian, and
endometrial cancers. In conclusion,
berberine has been found to efficiently inhibit viability, proliferation, and migration of
cancer cells, mainly, via induction of apoptosis by both mitochondrial dependent and -independent pathways. Additionally, structural modification of
berberine showed that
berberine analogues can improve its antitumor effects against gynaecological
cancers.